Maynard Um
-
-
-
-
-
-
-
Raymond James Starts Phathom Pharmaceuticals (PHAT) at Strong Buy, PT $28
-
-
-
-
-
-
-
Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 12c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Phathom (PHAT), PT $28, 'We leave our model unchanged, as our view reflected full 10-year exclusivity'
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) Announces Leadership Succession
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) spreader active in August 10 and November 10 calls
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

